Allergies News and Research

Latest Allergies News and Research

NIAID tackles drug-resistant tuberculosis

Tuberculosis (TB) has long been one of the world’s great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate. To help in the fight against drug-resistant TB, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has formulated an MDR and XDR TB research agenda.

22 Apr 2008

Monkey malaria - the next bird flu?

An expert at the NIH has highlighted the threat of an emergent highly virulent form of malaria, questioning whether the disease has made the jump from animal to man.

22 Apr 2008

U.S. and China at loggerheads over contaminated Heparin

Health officials in the U.S. appear to be at loggerheads with Chinese officials over the contamination of the blood-thinning drug Heparin.

22 Apr 2008

Commitment to conducting more basic research in search for HIV/AIDS vaccine 'prudent,' editorial says

The cancellation last fall of a Merck HIV/AIDS vaccine trial was "branded as a 'catastrophe' by one scientist and as setting the race for a cure 'back to square one' by others," a Washington Post editorial says, adding, "The hyperbole is understandable, but some perspective is in order."

21 Apr 2008

Immunotherapy could prevent allergic reactions to food

Researchers at National Jewish Medical and Research Center are conducting trials to evaluate a method to prevent allergic reactions to food.

17 Apr 2008

Asthma symptoms worse among nation's poor, urban children

American children with asthma living in poor, urban areas are particularly vulnerable to respiratory health problems, a consequence of poor air quality in inner-city neighborhoods.

17 Apr 2008

Alcon's PATANASE nasal spray approved by FDA for treatment of nasal allergy symptoms

Alcon, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PATANASE(R) (olopatadine hydrochloride) nasal spray for the relief of the symptoms of seasonal allergic rhinitis in patients 12 years of age and older.

16 Apr 2008

Special asthma equipment a waste of money

Researchers from the Cochrane Collaboration research group have reviewed 54 studies in order to assess just how well specialist asthma equipment worked; the studies involved over 3,000 people.

16 Apr 2008

New mucosal vaccine against anthrax effective in early tests

Early studies show that a new mucosal vaccine against anthrax has the potential to provide military personnel with more effective and efficient protection against a "popular" bioweapon, according to a study published in the journal Clinical and Vaccine Immunology (CVI).

13 Apr 2008

Traffic pollution exposure during first year of life leads to asthma, allergies and impaired respiratory function

Children exposed to high levels of air pollution during their first year of life run a greater risk of developing asthma, pollen allergies, and impaired respiratory function.

10 Apr 2008

Over-the-counter sale of child cough medicine for young children to be banned

As from September this year the over-the-counter sale of cough medicines for children under the age of two years old will be banned in Australia.

9 Apr 2008

Asthma and smoker's lung: dry airways play a key role

Dry airways may not only play a central role in the development of the inherited lung disease cystic fibrosis, but also in much more common acquired chronic lung diseases such as asthma and smoker's lung, the cigarette smoke-induced chronic obstructive pulmonary disease (COPD).

8 Apr 2008

Doctors are warning that climate change is already affecting people's health

Doctors in Australia are warning that by 2020 there will be a growing number of illnesses related to climate change.

7 Apr 2008

Clinical trial to test a novel HIV/AIDS vaccine

This new vaccine aims to overcome the problem of preexisting immunity to common vaccine vectors, which is thought to be a major problem in the developing world.

4 Apr 2008

Genetic mutations tied to immune comeback during therapy for HIV-1

Researchers with the Infectious Disease Clinical Research Program (IDCRP) at the Uniformed Services University of the Health Sciences (USU) here and the University of Texas Health Science Center at San Antonio have published a patient outcome study in the March 30 online edition of Nature Medicine that may signal a need for a change of thought in the management of HIV.

3 Apr 2008

Matrix registry probes adherence to clopidogrel at 1 year

A large community-based registry of patients treated with drug-eluting stents is providing important insight into how long patients with complex coronary artery disease typically stick to their doctors' orders to take clopidogrel, a drug that prevents unwanted blood clots; why they stop taking the drug; and the long-term consequences of that decision.

1 Apr 2008

Allergies dramatically impact sufferers' moods and how they feel about themselves

A new Harris Interactive phone survey conducted among 1,000 allergy sufferers, 1,000 consumers (both allergy sufferers and non-sufferers) and 300 physicians shows that beyond the sneezing, sniffling and watery eyes, allergies also have deep and emotional impacts on a sufferer's mood and self-perceptions.

24 Mar 2008

Asthma medicines often not prescribed as guidelines recommend

More than a decade after national guidelines were issued for asthma treatment, some patients still don't receive prescriptions for the inhalers that experts say offer the safest and most effective long-term control of the disease, a new study suggests.

20 Mar 2008

Discovery alters long standing concept of fixed protein structure

The thousands of proteins found in nature are simply strings of amino acids, assembled by genes, and scientists have long believed that they automatically fold themselves into uniquely fixed, 3-dimensional shapes to fire the engine of life.

19 Mar 2008

Scientists identify potential therapy targets for schistosomiasis

A research team supported by the National Institutes of Health (NIH) Roadmap and the National Institute of Allergy and Infectious Diseases (NIAID) has identified chemical compounds that hold promise as potential therapies for schistosomiasis, a parasitic disease that afflicts more than 200 million people worldwide.

18 Mar 2008